| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2025 | Jun 24, 2025 | Oncology Institute, Inc. | Director | Sell | 20.0 | -311,128 | -9.62% | ✗ | $813.7K |
| Mar 26, 2025 | Mar 28, 2025 | Oncology Institute, Inc. | Director | Buy | 100.0 | +1,358,448 | 325.62% | ✗ | $1.4M |
| Jun 18, 2024 | Jun 24, 2024 | AdaptHealth Corp. | Director | Sell | 48.8 | -3,559 | -0.81% | ✗ | $35.2K |
| May 7, 2024 | May 9, 2024 | AdaptHealth Corp. | CEO | Sell | 42.5 | -8,547 | -1.90% | ✗ | $84.2K |
| Feb 29, 2024 | Mar 4, 2024 | AdaptHealth Corp. | CEO | Sell | 87.5 | +12,222 | 2.78% | ✗ | $91.9K |
| Dec 29, 2023 | Jan 3, 2024 | AdaptHealth Corp. | CEO | Sell | 87.5 | +13,065 | 3.06% | ✗ | $67K |
| Aug 31, 2023 | Sep 5, 2023 | AdaptHealth Corp. | CEO | Sell | 82.5 | +6,790 | 1.71% | ✗ | $82.4K |
| Mar 17, 2023 | Mar 21, 2023 | Oncology Institute, Inc. | Director | Buy | 91.3 | +50,000 | 24.13% | ✗ | $27.5K |
| Nov 24, 2021 | Nov 24, 2021 | Oncology Institute, Inc. | Director | Buy | 86.3 | +5,000 | 5.49% | ✗ | $34.6K |
| Nov 23, 2021 | Nov 24, 2021 | Oncology Institute, Inc. | Director | Buy | 86.3 | +5,000 | 5.81% | ✗ | $31.7K |
| Nov 16, 2021 | Nov 18, 2021 | Oncology Institute, Inc. | Director | Buy | 78.8 | +1,000 | 1.17% | ✗ | $10.1K |